SANTA BARBARA, Calif., July 12, 2021 (GLOBE NEWSWIRE) — Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Firm”), a medical aesthetics firm uniquely centered on plastic surgeons, in the present day introduced that Andy Schmidt has been appointed Chief Monetary Officer (CFO) efficient instantly. As a key member of Sientra’s government management group, Mr. Schmidt will lead the Firm’s monetary operations.
“We’re extraordinarily happy to welcome a powerful chief like Andy to the Sientra group. His expertise with growth-oriented public firms will likely be invaluable as we work in the direction of increasing our market share and advancing the artwork of cosmetic surgery,” stated Ron Menezes, President and Chief Government Officer of Sientra. “We’re lucky to have a powerful finance group, and now a clean transition plan in place that permits us to take the following stride ahead within the development of our breast merchandise and monetary efficiency.”
Mr. Schmidt brings to Sientra greater than 20 years of economic management expertise and has efficiently directed the monetary, M & A and capital market methods of quite a few publicly held firms. Most lately, he served because the CFO of Guardion Well being Sciences, a Nasdaq-listed firm centered on scientific vitamin, diagnostics, and medical gadgets. Throughout his tenure at Guardion, Mr. Schmidt was a part of a group that raised $35 million and in addition restored the Corporations Nasdaq itemizing compliance. Beforehand, he served because the CFO of Iteris, Inc., a publicly traded world expertise firm. With a deal with inside and exterior strategic growth and execution, Mr. Schmidt accelerated progress and achieved file inventory efficiency. Prior, he was the CFO of publicly traded Smith Micro Software program, Inc. and Genius Merchandise, Inc. Earlier, he served in monetary management roles with Peregrine Methods and Mad Catz Interactive.
“I’m thrilled to hitch one of many quickest rising medical aesthetics firm within the U.S.,” stated Mr. Schmidt. “I stay up for work with the group to speed up Sientra’s progress and assist its aim to be a high two breast implant firm in two years.”
Mr. Schmidt acquired a Grasp of Science in Accountancy from San Diego State College and a Bachelor of Enterprise Administration in Finance from the College of Texas, Austin, TX. His honors embrace two educational awards / scholarships and a full athletic scholarship. In swimming, he earned All-America standing, gained the U.S. Nationwide Championship, and served as a member of the USA Nationwide Swimming Staff.
Headquartered in Santa Barbara, California, Sientra is a medical aesthetics firm uniquely centered on plastic surgeons. The Firm mission is to supply proprietary improvements and unparalleled partnerships that radically advance how plastic surgeons suppose, work and care for his or her sufferers. Sientra has developed a broad portfolio of merchandise with technologically differentiated traits, supported by unbiased laboratory testing and robust scientific trial outcomes. The Firm’s Breast Merchandise section contains its Sientra spherical and formed breast implants, the primary fifth technology breast implants authorized by the FDA on the market in the US, its ground-breaking Allox2® breast tissue expander with patented dual-port and integral drain expertise, and BIOCORNEUM®, the #1 performing, most popular and really useful scar gel of plastic surgeons(*).
Sientra makes use of its investor relations web site to publish vital details about the Firm, together with data that could be deemed materials to traders. Monetary and different details about Sientra is routinely posted and is accessible on the Firm’s investor relations web site at www.sientra.com.
(*) Information on file
This press launch comprises “forward-looking statements” inside the that means of Part 27A of the Securities Act of 1933, as amended, and Part 21E of the Securities Change Act of 1934, as amended, primarily based on administration’s present assumptions and expectations of future occasions and developments, which have an effect on or might have an effect on the Firm’s enterprise, technique, operations or monetary efficiency, and precise outcomes might differ materially from these expressed or implied in such statements because of quite a few dangers and uncertainties. Ahead-looking statements are made solely as of the date of this launch. The phrases ‘‘consider,’’ ‘‘might,’’ ‘‘may,’’ ‘‘might,’’ ‘‘will,’’ ‘‘purpose,’’ ‘‘estimate,’’ ‘‘proceed, ‘‘anticipate,’’ ‘‘intend,’’ ‘‘count on,’’ ‘‘plan,’’ ‘‘place,” or the damaging of these phrases, and comparable expressions that convey uncertainty of future occasions or outcomes are meant to determine estimates, projections and different forward-looking statements. Ahead-looking statements might embrace data regarding the Firm’s enlargement of its market share, the Firm’s development of the artwork of cosmetic surgery, the Firm’s acceleration of progress, and the Firm’s aim of turning into a high two implant firm in two years. Such statements are topic to dangers and uncertainties, together with the scope and length of the COVID-19 pandemic, the Firm’s capacity to recapture delayed procedures ensuing from the COVID-19 pandemic, the optimistic response from plastic surgeons and their sufferers to Sientra’s Breast Merchandise, the optimistic response from plastic surgeons and sufferers to Sientra’s advertising, gross sales and academic packages, and the power to execute on the Firm’s industrial, product growth and manufacturing initiatives. Extra components that would trigger precise outcomes to vary materially from these contemplated on this press launch may be discovered within the Threat Elements part of Sientra’s public filings with the Securities and Change Fee. All statements apart from statements of historic truth are forward-looking statements. The phrases ‘‘consider,’’ ‘‘might,’’ ‘‘may,’’ ‘‘might,’’ ‘‘will,’’ ‘‘purpose,’’ ‘‘estimate,’’ ‘‘proceed, ‘‘anticipate,’’ ‘‘intend,’’ ‘‘count on,’’ ‘‘plan,’’ ‘‘place,” or the damaging of these phrases, and comparable expressions that convey uncertainty of future occasions or outcomes are meant to determine estimates, projections and different forward-looking statements. You’re cautioned to not place undue reliance on these forward-looking statements, and such estimates, projections and different forward-looking statements converse solely as of the date they had been made, and, besides to the extent required by regulation, the Firm undertakes no obligation to replace or evaluate any estimate, projection or forward-looking assertion. Precise outcomes might differ from these set forth on this press launch as a result of dangers and uncertainties inherent within the Firm’s enterprise.
Investor Relations Contact